Santen Pharmaceutical Co Ltd (4536.T)
4536.T on Tokyo Stock Exchange
1,696JPY
25 Apr 2019
1,696JPY
25 Apr 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
¥1,696
¥1,696
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
1,390,944
1,390,944
52-wk High
¥2,061
¥2,061
52-wk Low
¥1,450
¥1,450
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Dec | 58,866.00 | 22.032 |
| Sep | 57,861.00 | 18.437 | |
| Jun | 56,483.00 | 16.794 | |
| FY 2018 | Mar '18 | 56,350.00 | 19.396 |
| Dec | 57,817.00 | 29.598 | |
| Sep | 54,826.00 | 15.300 | |
| Jun | 55,949.00 | 22.122 | |
| FY 2017 | Mar '17 | 48,429.00 | 11.201 |
| Dec | 52,838.00 | 11.399 | |
| Sep | 47,823.00 | 12.478 | |
| Jun | 50,006.00 | 17.613 |
*Note: Units in Millions ofYen
**Note: Units in Yen
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 1 | 60,300.00 | 60,300.00 | 60,300.00 | -- |
| Quarter Ending Dec-19 | 1 | 62,800.00 | 62,800.00 | 62,800.00 | -- |
| Year Ending Mar-19 | 9 | 234,756.00 | 238,000.00 | 231,600.00 | 230,470.00 |
| Year Ending Mar-20 | 10 | 245,885.00 | 253,000.00 | 240,600.00 | 243,656.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 1 | 7.13 | 7.13 | 7.13 | -- |
| Quarter Ending Dec-19 | 1 | 11.31 | 11.31 | 11.31 | -- |
| Year Ending Mar-19 | 10 | 79.58 | 86.80 | 68.50 | 74.82 |
| Year Ending Mar-20 | 11 | 80.50 | 98.30 | 50.63 | 83.28 |
| LT Growth Rate (%) | 1 | 4.60 | 4.60 | 4.60 | 7.40 |
Sales and Profit Figures in Japanese Yen (JPY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 28.99 | 29.30 | 32.55 | |
| P/E High - Last 5 Yrs. | 30.21 | 43.17 | 48.10 | |
| P/E Low - Last 5 Yrs. | 13.18 | 22.71 | 23.42 | |
| Beta | 0.58 | 0.86 | 0.87 | |
| Price to Sales (TTM) | 3.46 | 6.59 | 8.39 | |
| Price to Book (MRQ) | 2.73 | 5.12 | 5.27 | |
| Price to Tangible Book (MRQ) | 4.49 | 5.84 | 6.74 | |
| Price to Cash Flow (TTM) | 20.38 | 23.07 | 24.12 | |
| % Owned Institutions | -- | 0.87 | 1.65 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 1.49 | 1.43 | 1.35 | |
| Dividend Yield - 5 Year Avg | 1.65 | 1.45 | 1.37 | |
| Dividend 5 Year Growth Rate | 5.39 | 3.99 | 4.70 | |
| Payout Ratio(TTM) | 43.17 | 42.19 | 39.61 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 11.88 | 5.43 | 13.46 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 3.91 | 6.61 | 8.04 | |
| Sales - 5 Yr. Growth Rate | 11.72 | 10.48 | 10.85 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 24.23 | 45.67 | 47.73 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -52.93 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 7.31 | 9.90 | 10.46 | |
| Capital Spending - 5 Yr. Growth Rate | 23.70 | 15.26 | 14.68 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.62 | 2.07 | 2.18 |
| Current Ratio (MRQ) | 3.16 | 2.87 | 2.98 |
| LT Debt to Equity (MRQ) | 2.37 | 8.87 | 11.33 |
| Total Debt to Equity (MRQ) | 8.05 | 12.86 | 16.01 |
| Interest Coverage (TTM) | 47.31 | 32.48 | 28.44 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 61.88 | 52.10 | 52.41 | |
| Gross Margin - 5 Yr. Avg. | 63.12 | 49.66 | 50.39 | |
| EBITD Margin (TTM) | 21.40 | -- | -- | |
| EBITD - 5 Yr. Avg | 28.55 | 17.26 | 12.41 | |
| Operating Margin (TTM) | 16.45 | 13.53 | 5.77 | |
| Operating Margin - 5 Yr. Avg. | 24.66 | 13.69 | 8.01 | |
| Pre-Tax Margin (TTM) | 16.47 | 11.88 | 4.78 | |
| Pre-Tax Margin - 5 Yr. Avg. | 24.72 | 14.09 | 8.29 | |
| Net Profit Margin (TTM) | 12.02 | 8.79 | 1.52 | |
| Net Profit Margin - 5 Yr. Avg. | 16.64 | 10.58 | 4.70 | |
| Effective Tax Rate (TTM) | 27.04 | 22.12 | 22.13 | |
| Effective Tax Rate - 5 Yr. Avg. | 32.70 | 22.26 | 22.58 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 55,914,640 | 928,597,997 | 820,412,566 | |
| Net Income/Employee (TTM) | 6,721,026 | 105,162,136 | 92,866,183 | |
| Receivable Turnover (TTM) | 2.81 | 5.84 | 5.82 | |
| Inventory Turnover (TTM) | 2.98 | 2.57 | 3.41 | |
| Asset Turnover (TTM) | 0.63 | 0.93 | 0.90 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 7.53 | 10.98 | 10.60 | |
| Return on Assets - 5 Yr. Avg. | 10.07 | 12.41 | 11.78 | |
| Return on Investment (TTM) | 8.89 | 14.23 | 13.83 | |
| Return on Investment - 5 Yr. Avg. | 12.19 | 16.18 | 15.32 | |
| Return on Equity (TTM) | 9.56 | 15.46 | 15.25 | |
| Return on Equity - 5 Yr. Avg. | 13.23 | 17.07 | 16.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 1.95 | 10.83 | 11.72 |
| EPS (TTM) % | -56.40 | 5.54 | 7.31 |
| Dividend % | 4.00 | 9.14 | 5.39 |
Note: Units in Millions of US Dollars
Performance for Santen Pharmaceutical Co Ltd
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -2.24 | -7.67 | 99 | 29 |
| 13 Week | 13.02 | 7.65 | 99 | 42 |
| 26 Week | 15.03 | 1.57 | 99 | 44 |
| 52 Week | 14.80 | -7.87 | 99 | 11 |
| YTD | 22.03 | 9.84 | 99 | 38 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 53.66% |
| # of Holders: | 249 |
| Total Shares Held: | 214,541,032 |
| 3 Mo. Net Change: | 8,366,828 |
| # New Positions: | 4 |
| # Closed Positions: | 5 |
| # Increased Positions: | 56 |
| # Reduced Positions: | 55 |
| # Net Buyers: | 1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.